Yanfeng Gao

20PUBLICATIONS
15CO-AUTHORS
Molecular targetsMicro- and nanosystemsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical infection agents (incl. prions)Nanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Mar 20, 2026
A Bispecific Peptide-Drug Conjugate Targeting LAG-3 and PD-L1 Harnesses Antitumor Immunity of Macrophages and T Cells.

Yuzhen Qian, Yixuan Sun, Yahong Wu

|Jan 22, 2026
An Engineered Nanovesicles-Based Lysosome-Targeting Protein Degradation Platform (NV-TACs) for Cancer Immunotherapy.

Youmei Xiao, Xiuman Zhou, Xiaoshuang Niu

|Feb 10, 2025
Discovery of a Novel Selective and Cell-Active N6-Methyladenosine RNA Demethylase ALKBH5 Inhibitor.

Xianyuan Yang, Kaitao Huang, Xu-Nian Wu

|Feb 05, 2025
A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy.

Youmei Xiao, Zhuoying He, Wanqiong Li

|Jan 15, 2025
Self-assembled Palmitic Acid-modified Thymopentin Functions as a Delivery System of Nanovaccine for Cancer Immunotherapy.

Danhong Chen, Xiaoyun Ye, Ran Xu

Pageof 4